<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04201041</url>
  </required_header>
  <id_info>
    <org_study_id>PNB</org_study_id>
    <nct_id>NCT04201041</nct_id>
  </id_info>
  <brief_title>Pudendal Nerve Fluoroscopic Guided Pulsed Radiofrequency for Treatment of Superficial Dyspareunia</brief_title>
  <official_title>Trans-gluteal Versus Trans-vaginal Pudendal Nerve Fluoroscopic Guided Pulsed Radiofrequency for Treatment of Superficial Dyspareunia: a Prospective Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>South Egypt Cancer Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>South Egypt Cancer Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Superficial dyspareunia represents a major health problem especially for the newly wed
      couples. Pulsed radiofrequency for pudendal nerve is a non-neurolytic neuromodulatory method
      that is effective in relief of this type of pain. Objectives: to evaluate the efficacy of
      bilateral pudendal nerve fluoroscopic guided pulsed radiofrequency in treatment of
      intractable non-organic dyspareunia, and compare between trans-gluteal and transvaginal
      approaches regarding patient comfort and satisfaction.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 1, 2018</start_date>
  <completion_date type="Actual">March 25, 2020</completion_date>
  <primary_completion_date type="Actual">March 20, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in Numerical rating scale</measure>
    <time_frame>baseline reading -1 day reading-3 days postoperative reading</time_frame>
    <description>0 no pain and 10 maximum pain</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Superficial Dyspareunia</condition>
  <arm_group>
    <arm_group_label>trans-gluteal approach</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>received pudendal nerve pulsed radiofrequency through trans-gluteal approach</description>
  </arm_group>
  <arm_group>
    <arm_group_label>trans-vaginal approach</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>received pudendal nerve pulsed radiofrequency through trans-vaginal approach</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>pudendal nerve pulsed radiofrequency</intervention_name>
    <description>received pudendal nerve pulsed radiofrequency through trans-vaginal approach or trans-gluteal approach</description>
    <arm_group_label>trans-gluteal approach</arm_group_label>
    <arm_group_label>trans-vaginal approach</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  women aged between 16 and 46 years and from a near vicinity to our facility to make
             her available for follow-up

        Exclusion Criteria:

          -  We had excluded women with any abnormality in the transvaginal US guided imagining, or
             those with any evidence of local gynecological abnormalities on examination.
             Meanwhile, we had excluded those women with infection at site of injection,
             coagulopathy or other bleeding diathesis, pre-existing neurologic deficit in the
             targeted region, those with history of chronic opioid use and women who refused to
             participate in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>46 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alaa Elzohry, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>South Egypt Cancer Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>South Egypt Cancer Institute, Assiut University, Arab Republic of Egypt</name>
      <address>
        <city>Assiut</city>
        <zip>0020</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>December 11, 2019</study_first_submitted>
  <study_first_submitted_qc>December 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 16, 2019</study_first_posted>
  <last_update_submitted>April 7, 2020</last_update_submitted>
  <last_update_submitted_qc>April 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>South Egypt Cancer Institute</investigator_affiliation>
    <investigator_full_name>Alaa Ali M. Elzohry</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dyspareunia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

